Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Stereotaxis, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Stereotaxis, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Stereotaxis, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Stereotaxis, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| Stereotaxis, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
| Stereotaxis, Inc., Medical Equipment, Deal Details | 11 | 10 |
| Partnerships | 11 | 1 |
| Stereotaxis Enters Into An Agreement With Biosense Webster | 11 | 1 |
| Stereotaxis Enters Into An Agreement With Siemens Healthcare | 12 | 1 |
| Stereotaxis Expands Distribution Agreement With Strategic Catheter Partner | 13 | 1 |
| Stereotaxis Amends Co-Development Agreement With Biosense Webster | 14 | 1 |
| Equity Offering | 15 | 1 |
| Stereotaxis Announces Public Offering of Shares for Up To USD18 Million | 15 | 1 |
| Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million | 16 | 1 |
| Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million | 17 | 1 |
| Stereotaxis Completes Private Placement Of Shares For US$10 Million | 18 | 1 |
| Stereotaxis Completes Underwritten Public Offering Of US$16.79 Million | 19 | 2 |
| Stereotaxis, Inc. - Key Competitors | 21 | 1 |
| Key Employees | 22 | 1 |
| Locations And Subsidiaries | 23 | 1 |
| Head Office | 23 | 1 |
| Other Locations &Subsidiaries | 23 | 1 |
| Recent Developments | 24 | 1 |
| Strategy And Business Planning | 24 | 1 |
| Mar 30, 2015: Stereotaxis Extends Silicon Valley Bank Credit Facility by Three Years | 24 | 1 |
| Financial Announcements | 25 | 1 |
| Aug 09, 2016: Stereotaxis Reports 2016 Second Quarter Financial Results | 25 | 2 |
| May 09, 2016: Stereotaxis Reports 2016 First Quarter Financial Results | 27 | 1 |
| Aug 04, 2015: Stereotaxis Reports 2015 Second Quarter Financial Results | 28 | 2 |
| May 06, 2015: Stereotaxis Reports 2015 First Quarter Financial Results | 30 | 1 |
| Feb 25, 2015: Stereotaxis Reports 2014 Fourth Quarter and Full Year Financial Results | 31 | 2 |
| Corporate Communications | 33 | 1 |
| May 04, 2015: Stereotaxis Elects Medical Device Industry Veteran Duane DeSisto to Board of Directors | 33 | 1 |
| Product News | 34 | 1 |
| Mar 11, 2016: Journal of Cardiovascular Electrophysiology Publishes Special Issue Dedicated to Stereotaxis Technology | 34 | 1 |
| Jan 11, 2016: Stereotaxis Initiates Multi-Center Randomized Superiority Study On Ventricular Tachycardia Ablation Outcomes | 35 | 1 |
| May 13, 2015: Stereotaxis to Present New Clinical Evidence and Product Innovations at Heart Rhythm 2015 in Boston | 36 | 1 |
| Feb 18, 2015: CHU de Saint-Etienne Launches Second Stereotaxis Lab | 37 | 1 |
| Jan 13, 2015: Stereotaxis And Princess Grace Hospital Share Significant New Clinical Data For Remote Magnetic Ablation Procedures | 38 | 1 |
| Jan 08, 2015: Tucson Medical Center and Stereotaxis Bring First Vdrive With V-Loop System to U.S. | 39 | 1 |
| Jan 06, 2015: Stereotaxis Surpasses 75,000 Procedures With Remote Magnetic Navigation System | 40 | 1 |
| Jan 05, 2015: Stereotaxis Receives FDA Clearance Of Vdrive With V-Cas System. | 41 | 1 |
| Jan 05, 2015: Stereotaxis Receives Regulatory Approval Of Odyssey System In Japan | 42 | 1 |
| Product Approvals | 43 | 1 |
| Jan 05, 2015: Stereotaxis Receives FDA Clearance Of Vdrive With V-Cas System. | 43 | 1 |
| Jan 05, 2015: Stereotaxis Receives Regulatory Approval Of Odyssey System In Japan | 44 | 1 |
| Jan 05, 2015: Stereotaxis Receives Regulatory Approval Of Odyssey System In Japan | 45 | 1 |
| Clinical Trials | 46 | 1 |
| Jan 11, 2016: Stereotaxis Initiates Multi-Center Randomized Superiority Study On Ventricular Tachycardia Ablation Outcomes | 46 | 1 |
| Jan 13, 2015: Stereotaxis And Princess Grace Hospital Share Significant New Clinical Data For Remote Magnetic Ablation Procedures | 47 | 1 |
| Appendix | 48 | 1 |
| Methodology | 48 | 1 |
| About GlobalData | 48 | 1 |
| Contact Us | 48 | 1 |
| Disclaimer | 48 | 1 |